[1] 曹金金, 杜娟, 瞿姗娜, 等. 多靶点CAR-T细胞疗法在急性B淋巴细胞白血病中的应用[J]. 基础医学与临床, 2025, 45: 675-680. [2] S'liwa-Tytko P, Kaczmarska A, Lejman M, et al. Neurotoxicity associated with treatment of acute lymphoblastic leukemia chemotherapy and immunotherapy[J]. Int J Mol Sci, 2022, 23:5515. doi:10.3390/ijms23105515. [3] Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracere-bral hemorrhage: a guideline for healthcare professionals from the american heart association/american stroke association.[J]. Stroke, 2015, 46:2032-2060. [4] An SJ, Kim TJ, Yoon BW. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update[J].J Stroke, 2017, 19:3-10. [5] Shi K, Tian DC, Li ZG, et al. Global brain inflammation in stroke[J]. Lancet Neurol, 2019, 18:1058-1066. [6] Ye F, Garton HJL, Hua Y, et al. The role of thrombin in brain injury after hemorrhagic and ischemic stroke[J]. Transl Stroke Res, 2021, 12:496-511. [7] Sheth KN. Spontaneous intracerebral hemorrhage[J]. N Engl J Med, 2022, 387:1589-1596. [8] 韩星, 刘之岱, 刘姗, 等. 建立HPLC法检测血清尿刊酸并探讨其对儿童白血病的意义[J]. 基础医学与临床, 2017, 37: 939-944. [9] Maas MB, Naidech AM, Kim M, et al. Medication history versus point-of-care platelet activity testing in patients with intracerebral hemorrhage[J].J Stroke Cerebrovasc Dis, 2018, 27:1167-1173. [10] Baharoglu MI, Cordonnier C, Al-Shahi Salman R, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (patch): a randomised, open-label, phase 3 trial[J].Lancet, 2016, 387:2605-2613. [11] Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the management of patients with spontane-ous intracerebral hemorrhage: a guideline from the american heart association/american stroke association[J].Stroke, 2022, 53:e282-e361. doi:10.1161/STR.0000000000000407. [12] Mendelow AD, Gregson BA, Rowan EN, et al. STICH Ⅱ investigators. early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (stich Ⅱ): a randomised trial[J]. Lancet, 2013, 382:397-408. |